Showing 1251 - 1260 of 1612 for "South Korea" with applied filters
06 February 2023 by
Effective from December 9, 2022, the amended Guidelines for Examination of Unlawful Support (the “Guidelines”) expands the scope and modifies the standards of the existing safe harbor.
02 February 2023 by
Pfizer Inc. and its group companies (“Pfizer”) filed a suit bearing no. CS (COMM) No. 442 of 2021 titled as Pfizer Inc. & Ors. v. Triveni Interchem Private Limited & Ors. before the Hon’ble Delhi High Court, for infringement of patent IN 218291 for the compound Palbociclib.
31 January 2023 by
On October 7, 2021, Cigna group entered a stock purchase agreement to sell the equity interests of certain companies operating across seven countries, including LINA Life Insurance Co., Ltd. (“LINA Life”) and Cigna Korea, to Chubb group for USD $5.75 billion in cash (this event is hereby referred to as “the Transaction”). The Transaction was successfully completed on July 1, 2022. Kim & Chang advised Cigna Group in this transaction with respect to due diligence on LINA Life and other divested companies in Korea, review and execution of the stock purchase agreement and other legal advice necessary or required for the transaction.
18 January 2023 by
Much of what was discussed in the new administration's capital market policy prospects in early 2022 was carried over from election pledges. That may be why the general market protection policy was widely deployed. Regulatory authority’s intention to regulate unfair trade has been announced several times and is reflected in regulation and supervision in a variety of ways. Robust financial supervisory authorities, a revived joint investigation team for securities crimes at the prosecutor’s office, and special provisions regarding listed companies in the Financial Service and Capital Markets Act of Korea (“FSCMA”) are actively working together. Let's take a look at the impact this regulatory trend will have on listed companies in 2023.
17 January 2023 by
As the use of content platforms continues to grow around the world, Korea is revisiting the debate on who should be allowed to benefit from a person’s name, likeness, or other indicia of personal identity. In a global environment where almost anyone can obtain public notoriety, Korea is seeking to foster a balanced approach to unfair competition and IP enforcement by bolstering statutory protections during a time when avenues to profit from individual rights of publicity have expanded.
03 January 2023 by
As the year draws to a close, JIPYONG’s various practice groups look back at their achievements for the year 2022 and offer their insights for the coming year.
22 December 2022 by
The dispute resolution team of Legacy Law Offices LLP recently obtained two favourable orders for its client Usha Breco Ltd., in the matters of Usha Breco Ltd. & another v. Municipal Corporation, Shimla & another, and Usha Breco Ltd. & another v. Department of Tourism & Civil Aviation & another before the Himachal Pradesh High Court.
14 December 2022 by
The Korea Fair Trade Commission (“KFTC”) proposed revisions to the Merger Review Guidelines and the Merger Filing Guidelines to facilitate merger reviews of certain investments and to expedite their review process.
08 December 2022 by
The restructuring of Hanwha Energy Corporation’s (“HEC”) investments in the Gregadoo and Jindera solar farms in Australia (the “Assets”), which involved the transfer of the Assets from Hanwha Energy Singapore (“HES”) to Hanwha Energy Australia (“HEA”) in consideration of HES’s subscription of shares in HEA (hereby referred to as the “First Transaction”).
05 December 2022 by
In acquiring shares in a Korean entity, foreign investors often neglect to take into consideration that their transactions might be subject to the filing of a report with the Korea Fair Trade Commission (the “KFTC”), especially when the contemplated transaction is not a 100% acquisition.
